Discover how AI, machine learning, and multispecific designs are transforming antibody engineering, reducing development ...

The Cincinnati Children’s Center has expanded its capacity to manufacture cellular products for rare diseases.

We spoke to the facility’s director about the state of CGTs and how the industry can rebuild confidence in advanced ...

The firm expects its investment to create 700 direct jobs by the end of 2030 while contributing 3,000 indirect jobs across ...

The Octet® R8e BLI system delivers breakthrough sensitivity for low-abundance biomolecule detection, enabling precise kinetic ...

An expert from GeoVax discusses how China may be poised to overtake the US as the world leader in the industry.

This whitepaper examines how scalable magnetic separation technology can transform MAb production by eliminating key ...

Membrane-based chromatography matches resin-based antibody purification quality, while reducing process time, buffer use, and ...

Industry leaders reveal how process intensification is transforming biomanufacturing with dramatic gains in yield, cost reduction, and efficiency.

With the future of mRNA vaccines secure, an expert discusses the benefits of vaccine platform diversification.

Earlier this year, biotechnology company Biomar filed for voluntary bankruptcy proceedings. The company was one of the first institutions to establish itself in the Léon Technology Park in Monterrey, ...